These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 24475455)

  • 1. A story of microalbuminuria and diabetic nephropathy.
    Roshan B; Stanton RC
    J Nephropathol; 2013 Oct; 2(4):234-40. PubMed ID: 24475455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetic nephropathy and antioxidants.
    Tavafi M
    J Nephropathol; 2013 Jan; 2(1):20-7. PubMed ID: 24475422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients.
    Steinke JM; Mauer M;
    Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():958-63. PubMed ID: 18806710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ACE insertion/deletion (I/D) polymorphism and diabetic nephropathy.
    Rahimi Z
    J Nephropathol; 2012 Oct; 1(3):143-51. PubMed ID: 24475405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relative incidence of ESRD versus cardiovascular mortality in proteinuric type 2 diabetes and nephropathy: results from the DIAMETRIC (Diabetes Mellitus Treatment for Renal Insufficiency Consortium) database.
    Packham DK; Alves TP; Dwyer JP; Atkins R; de Zeeuw D; Cooper M; Shahinfar S; Lewis JB; Lambers Heerspink HJ
    Am J Kidney Dis; 2012 Jan; 59(1):75-83. PubMed ID: 22051245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracapillary proliferation in IgA nephropathy; recent findings and new ideas.
    Nasri H; Mubarak M
    J Nephropathol; 2015 Jan; 4(1):1-5. PubMed ID: 25657978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dermatological diseases in patients with chronic kidney disease.
    Gagnon1 AL; Desai T
    J Nephropathol; 2013 Apr; 2(2):104-9. PubMed ID: 24475435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DIABETIC RETINOPATHY, CLASSIFIED USING THE LESION-AWARE DEEP LEARNING SYSTEM, PREDICTS DIABETIC END-STAGE RENAL DISEASE IN CHINESE PATIENTS.
    Zhao L; Ren H; Zhang J; Cao Y; Wang Y; Meng D; Wu Y; Zhang R; Zou Y; Xu H; Li L; Zhang J; Cooper ME; Tong N; Liu F
    Endocr Pract; 2020 Apr; 26(4):429-443. PubMed ID: 31968187
    [No Abstract]   [Full Text] [Related]  

  • 9. Systematic review on urine albumin testing for early detection of diabetic complications.
    Newman DJ; Mattock MB; Dawnay AB; Kerry S; McGuire A; Yaqoob M; Hitman GA; Hawke C
    Health Technol Assess; 2005 Aug; 9(30):iii-vi, xiii-163. PubMed ID: 16095545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The health care costs of diabetic nephropathy in the United States and the United Kingdom.
    Gordois A; Scuffham P; Shearer A; Oglesby A
    J Diabetes Complications; 2004; 18(1):18-26. PubMed ID: 15019595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The analysis of risk factors for diabetic nephropathy progression and the construction of a prognostic database for chronic kidney diseases.
    Wang G; Ouyang J; Li S; Wang H; Lian B; Liu Z; Xie L
    J Transl Med; 2019 Aug; 17(1):264. PubMed ID: 31409386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What nephrolopathologists need to know about antiphospholipid syndrome-associated nephropathy: Is it time for formulating a classification for renal morphologic lesions?
    Mubarak M; Nasri H
    J Nephropathol; 2014 Jan; 3(1):4-8. PubMed ID: 24644536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current practices in the management of diabetic nephropathy.
    Chan G; Tang SC
    J R Coll Physicians Edinb; 2013; 43(4):330-2; quiz 333. PubMed ID: 24350318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A family-based strategy to identify genes for diabetic nephropathy.
    Covic AM; Iyengar SK; Olson JM; Sehgal AR; Constantiner M; Jedrey C; Kara M; Sabbagh E; Sedor JR; Schelling JR
    Am J Kidney Dis; 2001 Mar; 37(3):638-47. PubMed ID: 11228193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Turmeric: Reemerging of a neglected Asian traditional remedy.
    Khajehdehi P
    J Nephropathol; 2012 Apr; 1(1):17-22. PubMed ID: 24475382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and Management of Diabetic Nephropathy in Western Countries.
    Satirapoj B; Adler SG
    Kidney Dis (Basel); 2015 May; 1(1):61-70. PubMed ID: 27536666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of diabetic nephropathy among Type 2 diabetic patients in some of the Arab countries.
    Aldukhayel A
    Int J Health Sci (Qassim); 2017; 11(1):1-4. PubMed ID: 28293155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of diabetic nephropathy with angiotensin II receptor antagonist.
    Lewis EJ; Lewis JB
    Clin Exp Nephrol; 2003 Mar; 7(1):1-8. PubMed ID: 14586737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetic Nephropathy Remission and Regression Team Trial in Japan (DNETT-Japan): Rationale and study design.
    Shikata K; Haneda M; Koya D; Suzuki Y; Tomino Y; Yamada K; Maeda S; Kawakami N; Uzu T; Nishimura M; Sato C; Ogawa D; Makino H;
    Diabetes Res Clin Pract; 2010 Feb; 87(2):228-32. PubMed ID: 19889469
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.